Wang J et al. found that berberine can mediate apoptosis by inhibiting the EGFR pathway and enhance the efficacy of cetuximab or erlotinib in gastric cancer cell lines, which provide strong support for the potential of berberine in the treatment of DSM (Wang J. et al., 2016). Here, EGFR is linked to gastric cancer.